摘要 |
<p>The invention relates to tablets comprising deramciclane-fumarate of the Formula (I) whereby said tablets contain (related to the total weight) more than 50 % by weight of deramciclane-fumarate, 5-20 % by weight of a binder, 5-20 % by weight of microcrystalline cellu -lose having an average particle size below 30 ??m, 1-10 % by weight of a disintegrant, 0.5-4 % by weight of a lubricant, 0.5-4 % by weight of an anti-adhesive agent and 0-30 % by weight of a filler. Deramciclane-fumarate is a known anxiolytic active ingredient.</p> |